Company: PFSA
Filing Date: 2025-08-22
Form Type: S-1/A
Source: 0001213900-25-079829
Chunk: 217

Company: Profusa, Inc.
Filing Date: 2025-08-22
Form: S-1/A
Chunk 217
---
, when considered in combination with the other components of the executive compensation program. In general, Profusa provides a base salary level designed to reflect the executive officer’s scope of responsibility and accountability. While cash bonuses have been provided on a discretionary basis in prior years, Dr. Hwang did not receive a cash bonus with respect to 2024. Equity Awards While Profusa maintains an equity compensation plan, during 2024, Dr. Hwang did not receive any equity awards with respect to Profusa and, as of December 31, 2024, Dr. Hwang did not hold any outstanding equity awards with respect to Profusa. Summary Compensation Table The following table shows information regarding the compensation of Dr. Hwang, our sole named executive officer, for services performed in the years ended December 31, 2024 and 2023.

| Name and Principal Position          |     | Year |     |  Salary 
     ($) |     | Bonus 
 ($)   |     | Option 
 Awards 
 ($)(1) |     | Stock  
 Awards 
 ($)    |     | Non-Equity     
 Incentive Plan 
 Compensation   
 ($)            |     | All Other    
 Compensation 
 ($)          |     |   Total 
     ($) |
| Ben Hwang                            |     | 2024 |     | 470,000 |     | —     |     | —      |     | —      |     | —              |     | —            |     | 470,000 |
| Chief Executive Officer and Chairman |     | 2023 |     | 470,000 |     | —     |     | —      |     | —      |     | —              |     | —            |     | 470,000 |

Outstanding Equity Awards at 2023 Fiscal Year-End As of December 31, 2024, Dr. Hwang did not hold any outstanding equity awards with respect to Profusa. Additional Narrative Disclosure Severance Arrangements Profusa generally executes an offer of employment before an executive joins Profusa. This offer describes the basic terms of the executive’s employment, including his or her start date, starting salary, annual incentive target (if any) and equity awards. Profusa does not maintain a general severance policy. However, Dr. Hwang’s offer letter, dated January 1, 2013, provides that, upon a termination of employment by Profusa without cause, Profusa will pay him

139 six months’ base salary plus a pro -ratap